CClinicalTrials.gg
Sign In
CompletedNCT02973451Updated Sep 5, 2018

Laparoscopic Guided Transversus Abdominis Plane Block Versus Trocar Site Infiltration in Gynecologic Laparoscopy.

A Phase 2 interventional study of Laparoscopic Guided Bupivacaine and local Bupivacaine in Post Operative Local Anaesthesia, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-05.

Sponsored by Zagazig University · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

to compare between Laparoscopic Guided Transversus Abdominis Plane Block and Trocar Site Infiltration as postoperative analgesia in Gynecologic Laparoscopic surgery.

Read the detailed description

two groups of patients who are eligible for Gynecologic Laparoscopy were randomized to either Laparoscopic Guided Transversus Abdominis Plane Block or Trocar Site Infiltration at the end of the operation.

02

Conditions studied

  • Post Operative Local Anaesthesia
03

In context

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients Need Gynecologic Laparoscopy

Exclusion criteria

Exclusion Criteria:

  • diagnosed with chronic pain syndrome
  • have a postoperative intraperitoneal drain
  • necessitating alteration to laparotomy.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Laparoscopic

    Laparoscopic Guided Transversus Abdominis Plane Block using Bupivacaine

    Drug: Laparoscopic Guided Bupivacaine

  • Active comparator
    local

    Trocar Site Infiltration of Bupivacaine

    Drug: local Bupivacaine

Interventions

  • DrugLaparoscopic Guided Bupivacaine

    Bupivacaine Laparoscopic GuidedTransversus Abdominis Plane Block

    Also known as: marcaine

  • Druglocal Bupivacaine

    Bupivacaine Trocar Site Infiltration

    Also known as: marcaine

06

What researchers measure

Primary outcomes

  1. Pain Scores

    Time frame: 24 Hours

07

Study locations

1 site
  • Zagazig University
    Zagazig, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02973451
Lead sponsor
Zagazig University
Responsible party
IBRAHIM ABD ELGAFOR (assistant professor, Zagazig University) — Principal investigator
First posted
Nov 25, 2016
Start date
Apr 2016
Primary completion
Jul 2017
Completion
Aug 2017
Last update
Sep 5, 2018

Study contacts

ibrahim A el sharkwy, MD
principal investigator · Zagazig University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Zagazig University

Start the discussion